Ananya Anmangandla
Cornell University(US)Aptose Biosciences (United States)(US)
Publications by Year
Research Areas
Calcium signaling and nucleotide metabolism, RNA Research and Splicing, Sirtuins and Resveratrol in Medicine, PARP inhibition in cancer therapy, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Histone H2B Deacylation Selectivity: Exploring Chromatin’s Dark Matter with an Engineered Sortase(2022)60 cited
- → Pharmacological Advantage of SIRT2-Selective versus pan-SIRT1–3 Inhibitors(2021)26 cited
- → Bacterial Riboswitches and Ribozymes Potently Activate the Human Innate Immune Sensor PKR(2016)18 cited
- → The Acyl-CoA Specificity of Human Lysine Acetyltransferase KAT2A(2022)16 cited
- → A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain(2023)13 cited
- → Mapping multiple RNA modifications simultaneously by proximity barcode sequencing(2024)4 cited
- → Iso-ADP-Ribose Fluorescence Polarization Probe for the Screening of RNF146 WWE Domain Inhibitors(2024)2 cited
- → GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains(2024)1 cited
- → Correction to “A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain”(2024)
- Investigation and Structural Analysis of Innate Immune Sensor PKR Activation by the Clostridia Bolteae Twister Ribozyme(2017)